Insulet | PODD - Pre Tax Profit

Stock Price
199.90
Daily Change
-3.61 -1.77%
Monthly
-16.84%
Yearly
-24.49%
Q2 Forecast
198.16

Insulet reported $140.2M in Pre-Tax Profit for its fiscal quarter ending in December of 2025.





Pre Tax Profit Change Date
Abbott USD 2.36B 178M Dec/2025
Align Technology USD 176.6M 81.86M Dec/2025
AtriCure USD 2.36M 2.45M Dec/2025
Avanos Medical USD -1.2M 74.7M Sep/2025
Baxter International USD 121M 12M Sep/2025
Becton, Dickinson and Co. USD 393M 117M Dec/2025
Boston Scientific USD 938M 3M Sep/2025
Cardinal Health USD 598M 214M Sep/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Eli Lilly USD 7.23B 456M Sep/2025
Globus Medical USD 143.99M 44.18M Sep/2025
ICU Medical USD 70.3M 36.62M Sep/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Merit Medical Systems USD 73.18M 29.8M Sep/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Solventum Corp USD 511M 149M Sep/2025
Stryker USD 1.03B 13M Sep/2025
Tandem Diabetes Care USD -25.14M 32.58M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
West Pharmaceutical Services USD 170.1M 8.1M Sep/2025
Zimmer Biomet Holdings USD 418.7M 194.1M Sep/2025